Factors of imatinib resistance in chronic myeloid leukemia

被引：0
|
作者：
Kajtar, B. [1 ]
Alpar, D. [1 ]
Toth, J. [1 ]
Laszlo, R. [1 ]
Jakso, R. [1 ]
Kereskai, L. [1 ]
Nagy, Z. [1 ]
Pajor, L. [1 ]
机构：
[1] Univ Pecs, Dept Pathol, H-7622 Pecs, Hungary
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70053-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [21] Imatinib Mesylate in Chronic Myeloid Leukemia
    Mishra, Pravas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
  • [22] Imatinib therapy in chronic myeloid leukemia
    Crossman, LC
    O'Brien, SG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) : 605 - +
  • [23] Evolution of resistance to imatinib mesilate and multidrug resistance in accelerated phase of chronic myeloid leukemia
    Kruglov, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 455 - 456
  • [24] Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?
    White, Deborah L.
    LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1022 - 1023
  • [25] Molecular resistance to imatinib in chronic myeloid leukemia. From the Italian Cooperative Study Group on chronic myeloid leukemia.
    Martinelli, G
    Soverini, S
    Rosti, G
    Bassi, S
    Amabile, M
    Trabacchi, E
    Giannini, B
    Cilloni, D
    Izzo, B
    de Vivo, A
    Testoni, N
    Cambrin, GR
    Bonifazi, F
    Luatti, S
    Gottardi, E
    Alberti, D
    Pane, F
    Salvatore, F
    Saglio, G
    Baccarani, M
    BLOOD, 2003, 102 (11) : 312B - 312B
  • [26] Factors Influencing Physician Recommendation for Imatinib Mesylate in Chronic Phase Chronic Myeloid Leukemia
    Shrividya Iyer
    William R. Doucette
    Drug information journal : DIJ / Drug Information Association, 2006, 40 : 141 - 153
  • [27] Factors influencing physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia
    Iyer, Shrividya
    Doucette, William R.
    DRUG INFORMATION JOURNAL, 2006, 40 (02): : 141 - 153
  • [28] Treatment of Chronic Phase Chronic Myeloid Leukemia with Imatinib
    Ganesan, Prasanth
    Rajendranath, Rejiv
    Kandakumar, Vignesh
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF PEDIATRICS, 2015, 82 (03): : 235 - 239
  • [29] Treatment of Chronic Phase Chronic Myeloid Leukemia with Imatinib
    Prasanth Ganesan
    Rejiv Rajendranath
    Vignesh Kandakumar
    Tenali Gnana Sagar
    The Indian Journal of Pediatrics, 2015, 82 : 235 - 239
  • [30] PREDICTIVE MOLECULAR MARKERS OF IMATINIB RESISTANCE AND PROGNOSIS IN CHRONIC MYELOID LEUKEMIA PATIENTS
    Elias, M. H.
    Au, Z. A.
    Husin, A.
    Sulong, S.
    Hassan, R.
    Goh, A. S.
    Wahid, S. F. A.
    Baba, A. A.
    Ankathil, R.
    ANNALS OF ONCOLOGY, 2013, 24
12345